Benefit-Risk Assessment in Drug Development i
Benefit-Risk Assessment in Drug Development
PhD thesis by Sinan B. Sarac
Supervisors:
Professor Emeritus Erik Mosekilde, DTU Physics
Affiliate Professor Morten Colding-Jørgensen, Quantitative Clinical Pharmacology, Novo
Nordisk A/S
Affiliate Professor Steffen Thirstrup, Danish Health and Medicines Authority
Examiners:
Professor Per Helboe, University of Copenhagen, Denmark
Professor Stuart Walker, University of Wales, Cardiff, UK
Professor Ole Lund, DTU Systems Biology
Chairman:
Associate Professor Jørn Bindslev Hansen, DTU Physics
Submitted:
December 23rd 2011
Defended:
April 16th 2012